GEN Exclusives

More »

Best Science Apps

More »
Apr 01, 2014 (Vol. 34, No. 7)

Cytometry

URL:bit.ly/1mdTAKi
  • Protocol feature, nice descriptions of products
  • Very commercial in nature
Platform: iPad/iPhone (also available for Android)  
Cost: Free

On the surface, the Cytometry app by Invitrogen may seem like little more than a product catalog. While it certainly is product-centric, the app warrants inclusion in this column because of the particular organization of the product information into informational/educational categories and because of the built-in protocol features. The app is organized into different categories corresponding to various applications of flow cytometry, including immune-phenotyping, antibody labeling, cell viability, and phagocytosis. Within a given category, the available reagents for that specific type of experiment are given. In this way, researchers are able to get a sense of the types of analyses that are possible and the reagents that are available (albeit just from Life Technologies). Additionally, the complete labeling protocol is given for each reagent, complete with an interactive timer feature for each incubation step. Simply tapping the clock icon will start a timer corresponding to the correct amount of time.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?